These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 9047795)

  • 1. [Familial hypertrophic cardiomyopathy].
    Anan R; Tanaka H
    Ryoikibetsu Shokogun Shirizu; 1996; (14):53-6. PubMed ID: 9047795
    [No Abstract]   [Full Text] [Related]  

  • 2. The molecular genetics of hypertrophic cardiomyopathy: prognostic implications.
    Sorajja P; Elliott PM; McKenna WJ
    Europace; 2000 Jan; 2(1):4-14. PubMed ID: 11225594
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular basis of hypertrophic cardiomyopathy.
    Cuda G; Perrotti N; Perticone F; Mattioli PL
    Cardiologia; 1995 Mar; 40(3):195-8. PubMed ID: 7664310
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hypertrophic cardiomyopathy].
    Arbustini E; Dal Bello B
    Cardiologia; 1999 Dec; 44 Suppl 1(Pt 1):213-23. PubMed ID: 12497910
    [No Abstract]   [Full Text] [Related]  

  • 5. A rapid protocol for cardiac troponin T gene mutation detection in familial hypertrophic cardiomyopathy.
    Gerull B; Osterziel KJ; Witt C; Dietz R; Thierfelder L
    Hum Mutat; 1998; 11(2):179-82. PubMed ID: 9482583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Familial hypertrophic cardiomyopathy: genes, mutations and animal models. A review].
    Ramírez CD; Padrón R
    Invest Clin; 2004 Mar; 45(1):69-99. PubMed ID: 15058760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertrophic cardiomyopathy: a case study in converging pathways.
    Robbins J
    J Clin Invest; 1996 Dec; 98(11):2433-4. PubMed ID: 8958201
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of two familial hypertrophic cardiomyopathy-causing mutations on alpha-tropomyosin structure and function.
    Golitsina N; An Y; Greenfield NJ; Thierfelder L; Iizuka K; Seidman JG; Seidman CE; Lehrer SS; Hitchcock-DeGregori SE
    Biochemistry; 1997 Apr; 36(15):4637-42. PubMed ID: 9109674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and application of linkage analysis in genetic diagnosis of familial hypertrophic cardiomyopathy.
    Mogensen J; Andersen PS; Steffensen U; Christiansen M; Egeblad H; Gregersen N; Børglum AD
    J Med Genet; 2001 Mar; 38(3):193-8. PubMed ID: 11303515
    [No Abstract]   [Full Text] [Related]  

  • 10. [Genetic changes and clinical management in familial hypertrophic cardiomyopathy].
    Domal-Kwiatkowska D; Smolik S; Mazurek U; Moric E; Polońska J; Nowalany-Kozielska E; Glanowska G; Wodniecki J; Szarek J; Wilczewski P; Kozakiewicz K; Tendera M; Wilczok T
    Wiad Lek; 2000; 53(1-2):4-21. PubMed ID: 10806915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-existence of frataxin and cardiac troponin T gene mutations in a child with Friedreich Ataxia and familial hypertrophic cardiomyopathy.
    Cuda G; Mussari A; Concolino D; Costanzo FS; Strisciuglio P
    Hum Mutat; 2002 Mar; 19(3):309-10. PubMed ID: 11857753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features of hypertrophic cardiomyopathy caused by an Arg278Cys missense mutation in the cardiac troponin T gene.
    Theopistou A; Anastasakis A; Miliou A; Rigopoulos A; Toutouzas P; Stefanadis C
    Am J Cardiol; 2004 Jul; 94(2):246-9. PubMed ID: 15246915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular genetics of familial cardiomyopathies.
    Coonar AS; McKenna WJ
    Adv Genet; 1997; 35():285-324. PubMed ID: 9348651
    [No Abstract]   [Full Text] [Related]  

  • 14. Recent advances in the molecular genetics of hypertrophic cardiomyopathy.
    Marian AJ; Roberts R
    Circulation; 1995 Sep; 92(5):1336-47. PubMed ID: 7648684
    [No Abstract]   [Full Text] [Related]  

  • 15. Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives.
    Andersen PS; Havndrup O; Hougs L; Sørensen KM; Jensen M; Larsen LA; Hedley P; Thomsen AR; Moolman-Smook J; Christiansen M; Bundgaard H
    Hum Mutat; 2009 Mar; 30(3):363-70. PubMed ID: 19035361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How should hypertrophic cardiomyopathy be classified?: Molecular diagnosis for hypertrophic cardiomyopathy: Not ready for prime time.
    Elliott P; McKenna WJ
    Circ Cardiovasc Genet; 2009 Feb; 2(1):87-9; discussion 89. PubMed ID: 20031570
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical and molecular genetics of hypertrophic cardiomyopathy].
    Sepp R; Csanády M
    Orv Hetil; 1998 Aug; 139(33):1965-71. PubMed ID: 9734214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiomyopathy: molecular and immunological aspects (review).
    Takeda N
    Int J Mol Med; 2003 Jan; 11(1):13-6. PubMed ID: 12469210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symposium on gene abnormalities in medical diseases. 3. Molecular genetics of hypertrophic cardiomyopathy in Japan.
    Kimura A
    Intern Med; 1997 Feb; 36(2):152-4. PubMed ID: 9099608
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiac troponin T mutations in Chinese patients with hypertrophic cardiomyopathy.
    Wu HF; Yang D; Wan WH; Bian ZP; Xu JD; Ma WZ; Zhang JN
    Chin Med J (Engl); 2004 Jun; 117(6):944-6. PubMed ID: 15198905
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.